Acadian Asset Management
BIOC

Acadian Asset Management’s Biocept, Inc. BIOC Stock Holding History

Acadian Asset Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-247
Closed – – 1927
2023
Q2 		$0 Sell
247
-215
-47% -$1.22K ﹤0.01% 1969
2023
Q1 		$4K Hold
462
– – ﹤0.01% 1700
2022
Q4 		$7K Hold
462
– – ﹤0.01% 1744
2022
Q3 		$12K Hold
462
– – ﹤0.01% 1634
2022
Q2 		$13K Sell
462
-424
-48% -$19.3K ﹤0.01% 1636
2022
Q1 		$61K Sell
886
-1,191
-57% -$93.6K ﹤0.01% 1445
2021
Q4 		$225K Buy
+2,077
New +$239K ﹤0.01% 1200

Other funds holding BIOC

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Acadian Asset Management's BIOC Position: Q3 2023 in Review

Acadian Asset Management sold out of Biocept, Inc. (BIOC) in Q3 2023, closing a stake of 247 shares.

Acadian Asset Management first reported a position in BIOC in Q4 2021 and held it in 7 quarters. The position peaked at $225K in Q4 2021. 13 funds tracked by Wall St. Rank hold BIOC as of Q3 2023.

  • Acadian Asset Management reported no remaining Biocept, Inc. position as of Q3 2023 after selling out during the quarter.
  • Acadian Asset Management sold 247 Biocept, Inc. shares in Q3 2023.
  • Acadian Asset Management first reported a position in Biocept, Inc. in Q4 2021 and held it in 7 quarters.
  • Acadian Asset Management's Biocept, Inc. position peaked at $225K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2023.

Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.